Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Sep. 30, 2024 |
|
| Finite Lived Intangible Assets [Line Items] | |||
| Net Carrying Amount | $ 8,137 | $ 8,562 | |
| Amortization expense | 400 | $ 400 | |
| Novartis | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 24,857 | 24,857 | |
| Accumulated Amortization | 16,720 | 16,295 | |
| Impairment | 0 | 0 | |
| Net Carrying Amount | 8,137 | 8,562 | |
| Novartis | Patents | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 21,728 | 21,728 | |
| Accumulated Amortization | 15,261 | 14,873 | |
| Impairment | 0 | 0 | |
| Net Carrying Amount | $ 6,467 | $ 6,855 | |
| Useful Lives (in years) | 14 years | 14 years | |
| Novartis | License | |||
| Finite Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | $ 3,129 | $ 3,129 | |
| Accumulated Amortization | 1,459 | 1,422 | |
| Impairment | 0 | 0 | |
| Net Carrying Amount | $ 1,670 | $ 1,707 | |
| Useful Lives (in years) | 21 years | 21 years | |
| X | ||||||||||
- Definition Finite-Lived Intangible Assets, Impairment No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|